Last reviewed · How we verify
NCT06225076
Efficacy of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke
NA trial testing Comprehensive rehabilitation in Bulbar Palsy. Withdrawn.
15 April 2024
Quick facts
| Lead sponsor | Zeng Changhao |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Start date | 30 January 2024 |
| Primary completion | 15 April 2024 |
| Estimated completion | 30 May 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Comprehensive rehabilitation
- Stellate ganglion block — full drug profile →
- Lidocaine Hydrochloride (Lidocaine Hydrochloride) — full drug profile →
Conditions studied
- Bulbar Palsy — all drugs for Bulbar Palsy →
Sponsor
Zeng Changhao — full company profile →
Who can join
18 and older, any sex, with Bulbar Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in 3 hospitals in China. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 20-day treatment, video fluoroscopic swallowing study, and penetration-aspiration scale, Functional Oral Intake Scale, Flexible laryngoscope are used to assess swallowing function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06225076
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Comprehensive rehabilitation
Trials testing the same drug.
- NCT06319534 — Stellate Ganglion Block in Bulbar Palsy · NA · completed
- NCT06301737 — Lidocaine Injection: A Nove Block Therapy for Stroke-related Dysphagia · NA · completed
Other Zeng Changhao trials
Trials by the same sponsor.
- NCT06265792 — Efficacy of Stellate Ganglion Block in Obstructive Sleep Apnea · NA · unknown
- NCT06265844 — Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma · NA · unknown
- NCT06265779 — Transcranial Direct Current Stimulation Combined With Intermittent Oral to Esophageal Tube on Dysphagia · NA · unknown
- NCT06255353 — Effect of Different Feeding Modes in Intracerebral Hemorrhage · NA · completed
- NCT06265805 — Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06225076 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zeng Changhao
- Last refreshed: 5 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06225076.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing